Absorbable Sutures Sales

Absorbable Sutures Sales Market Outlook

The global absorbable sutures market is projected to reach approximately USD 5.5 billion by 2035, expanding at a compound annual growth rate (CAGR) of around 6.5% during the forecast period from 2025 to 2035. The rising prevalence of chronic diseases and the growing number of surgical procedures worldwide are significant drivers contributing to the robust growth of this market. Moreover, the increasing preference for minimally invasive surgeries, coupled with advancements in surgical techniques and materials, further fuels market expansion. The enhanced focus on patient safety and the need for efficient wound healing are also pivotal factors that support the growth of the absorbable sutures market. As healthcare facilities and providers recognize the benefits of absorbable sutures, including reduced risk of infection and elimination of suture removal procedures, the demand for these products is expected to rise substantially.

Growth Factor of the Market

The absorbable sutures market is witnessing significant growth due to several interconnected factors. One of the primary growth drivers is the increasing number of surgical procedures performed globally, which has been rising due to an aging population and the prevalence of lifestyle-related diseases. Additionally, advancements in suture technology, such as the development of new materials and absorption rates, enhance the performance of absorbable sutures, making them more appealing to surgeons and healthcare providers. Furthermore, the growing trend towards outpatient surgeries and minimally invasive procedures has heightened the demand for absorbable sutures, as these products offer the convenience of eliminating the need for suture removal. Moreover, healthcare providers are increasingly adopting absorbable sutures due to their effectiveness in minimizing complications and improving patient outcomes. Lastly, increasing investments by companies in research and development to create innovative suture solutions are also propelling market growth.

Key Highlights of the Market

• The market is expanding at a CAGR of 6.5% from 2025 to 2035.
• Minimally invasive surgeries are significantly driving the demand for absorbable sutures.
• Advancements in suture technology are enhancing product performance.
• Growing aging population and prevalence of chronic diseases are key factors for market growth.
• The emphasis on patient safety is increasing the adoption of absorbable sutures.

By Product Type

Natural Sutures :

Natural sutures, such as catgut, are derived from collagen obtained from the intestines of animals. These types of sutures have been used for centuries due to their biocompatibility and effective absorption rates. Their primary advantage lies in their ability to promote healing while being gradually absorbed by the body over time. Natural sutures are often preferred in cases where minimal scar formation is desired. However, their use has been declining due to the introduction of synthetic alternatives that offer more predictable absorption rates and less variability. Despite this, natural sutures still hold a significant share in specific applications, particularly in general surgeries and gynecological procedures where tissue integration is vital.

Synthetic Sutures :

Synthetic sutures are manufactured from various polymers and are designed to provide consistent performance and predictable absorption rates. Common materials include polyglycolic acid and polyglactin, which are favored for their strength and ease of handling. The use of synthetic sutures is prevalent across various surgical applications, including orthopedic and plastic surgeries. Their advantages include reduced tissue reactivity, enhanced knot security, and broad availability. Additionally, synthetic sutures can be engineered to suit specific surgical needs, leading to their increasing adoption in modern surgical practices. The demand for synthetic sutures is on the rise, driven by ongoing innovations and the growing emphasis on patient safety and surgical outcomes.

Composite Sutures :

Composite sutures are designed to combine the properties of both natural and synthetic materials, aiming to enhance performance in various surgical applications. By leveraging the advantages of both types, composite sutures provide unique benefits such as improved tensile strength and better absorption profiles. These sutures are particularly beneficial in complex surgeries where multifaceted tissue approximation is required. The increasing complexity of surgical procedures and the need for versatile suture materials are driving the growth of the composite sutures segment. As surgeons seek solutions that can perform well across a range of environments, the market for composite sutures is expected to expand considerably.

Monofilament Sutures :

Monofilament sutures consist of a single, solid strand of material, which minimizes tissue trauma and decreases the risk of infection. These sutures are highly favored in delicate surgeries, such as ophthalmic and vascular procedures, due to their smooth passage through tissues. Additionally, monofilament sutures exhibit minimal capillarity, meaning they do not harbor bacteria or fluids, further enhancing their safety profile. The increasing demand for surgical precision and the need for materials that reduce healing time are propelling the monofilament suture market. As surgical techniques evolve, the adoption of monofilament sutures is likely to increase significantly across different specialties.

Multifilament Sutures :

Multifilament sutures are composed of multiple strands twisted or braided together, resulting in increased flexibility and ease of handling. They are particularly advantageous in applications requiring strong knot security and stability. The multifilament structure allows for better tissue approximation, making them suitable for various surgical procedures, including orthopedic and general surgeries. However, these sutures can be associated with increased tissue reactivity and infection risk compared to monofilament sutures. The growth of the multifilament suture market is driven by ongoing advancements in suture technology and an increasing understanding of the unique benefits they provide in complex surgical contexts.

By Application

General Surgeries :

General surgeries encompass a broad range of procedures performed on various body parts. Absorbable sutures are commonly employed in general surgery due to their versatility and effectiveness in closing incisions and wounds. Their use is particularly beneficial in procedures involving soft tissues, such as appendectomies, hernia repairs, and laparoscopic surgeries. The increasing number of general surgical procedures, along with the emphasis on patient recovery and wound healing, drives the demand for absorbable sutures in this segment. The ongoing development of new suture materials and technology further contributes to the growth of absorbable sutures in general surgical applications.

Gynecological Surgeries :

Gynecological surgeries often require precise techniques and materials that promote optimal healing with minimal scarring. Absorbable sutures play a crucial role in gynecological procedures, including cesarean sections and hysterectomies. The demand for absorbable sutures in this application has been bolstered by the growing preference for minimally invasive surgical approaches, which facilitate quicker recovery times and reduced post-operative complications. As healthcare providers increasingly recognize the benefits of absorbable sutures in supporting patient outcomes, the market for this segment continues to expand. Furthermore, evolving surgical techniques and increasing awareness about patient safety further enhance the adoption of absorbable sutures in gynecological practices.

Orthopedic Surgeries :

Orthopedic surgeries often involve complex procedures that require strong and reliable suturing solutions. The use of absorbable sutures in orthopedic surgeries is growing due to their ability to provide stability and support in soft tissue repairs, ligament reconstructions, and fracture fixation. The emphasis on improving patient recovery times and reducing the risk of complications has propelled the adoption of absorbable sutures in this field. Additionally, advancements in suture technology, such as the development of bioactive and biomechanical materials, are enhancing the performance of absorbable sutures in orthopedic applications, thus driving market growth in this segment.

Ophthalmic Surgeries :

The ophthalmic surgery segment has a unique requirement for sutures that are gentle and compatible with delicate eye tissues. Absorbable sutures are particularly beneficial in this field, as they provide effective wound closure without the need for subsequent suture removal, thereby minimizing patient discomfort. The increasing prevalence of eye-related conditions and the growing number of ophthalmic procedures are contributing to the demand for absorbable sutures in this segment. Furthermore, advancements in ophthalmic surgical techniques and the introduction of new absorbable suture materials are expected to drive the growth of this market area, as they enhance surgical precision and patient outcomes.

Others :

In addition to the primary applications mentioned, absorbable sutures are utilized in various other surgical procedures, including plastic surgeries, urological surgeries, and cardiovascular surgeries. The versatility of absorbable sutures allows them to be adapted for numerous uses, catering to specific needs across different specialties. The growing recognition of the benefits of absorbable sutures in reducing infection risk and facilitating faster healing times continues to drive their adoption in these diverse applications. As surgical practices evolve and the demand for effective wound closure solutions increases, the "others" segment of the absorbable sutures market is anticipated to experience significant growth.

By Distribution Channel

Hospitals :

Hospitals remain the primary distribution channel for absorbable sutures, accounting for a significant share of the market. The high volume of surgical procedures performed in hospitals, coupled with the availability of specialized surgical teams, drives the demand for absorbable sutures in this setting. Hospitals typically stock a wide range of suture types and materials to cater to various surgical needs and specialties. Furthermore, the increasing number of surgical interventions, supported by advancements in hospital infrastructure and surgical technology, is propelling the growth of absorbable sutures in the hospital setting. As healthcare providers focus on optimizing patient safety and outcomes, the reliance on hospitals for these products is expected to remain strong.

Specialty Clinics :

Specialty clinics are emerging as vital distribution channels for absorbable sutures, particularly for specific surgical specialties such as orthopedics, gynecology, and ophthalmology. The growth of specialty clinics is driven by the increasing preference for outpatient procedures and the rising demand for specialized surgical care. These clinics often emphasize the need for high-quality absorbable sutures tailored to their specific surgical applications. As the number of specialty clinics continues to rise, the demand for absorbable sutures within this distribution channel is expected to grow, reflecting the ongoing trend toward personalized surgical care.

Ambulatory Surgical Centers :

Ambulatory surgical centers (ASCs) are gaining prominence as a distribution channel for absorbable sutures, driven by the growing trend towards outpatient surgeries. As ASCs provide a cost-effective solution for various surgical procedures, the demand for absorbable sutures in this setting is increasing. The ability of ASCs to offer shorter recovery times and minimize hospital stays aligns with the advantages of absorbable sutures, which eliminate the need for suture removal. Furthermore, as the healthcare industry continues to evolve, the role of ASCs in the absorbable sutures market is expected to expand, supported by ongoing advancements in surgical techniques and patient care.

Online Sales :

The rise of e-commerce is transforming the distribution landscape for absorbable sutures, with online sales becoming an increasingly popular channel. The online sale of medical supplies has gained traction due to the convenience and accessibility it offers to healthcare providers and institutions. As more hospitals and clinics turn to online platforms for their procurement needs, the demand for absorbable sutures in this channel is expected to grow. Additionally, online sales provide a broader selection of suture types and brands, allowing healthcare providers to choose products that best fit their needs. The increasing emphasis on digitalization in the healthcare sector is further propelling the growth of online sales as a vital distribution channel for absorbable sutures.

By Material Type

Polyglactin :

Polyglactin sutures are made from a copolymer of glycolide and lactide, which provides excellent tensile strength and predictable absorption rates. These sutures are widely used in various surgical procedures, particularly in soft tissue approximation and ligation. Polyglactin sutures are known for their minimal tissue reactivity and smooth passage through tissues, making them a popular choice among surgeons. As the demand for reliable and efficient wound closure options continues to grow, the market for polyglactin sutures is expected to expand significantly, supported by advancements in manufacturing techniques and ongoing innovations in suture technology.

Poliglecaprone :

Poliglecaprone sutures are synthetic absorbable sutures known for their excellent handling properties and low tissue reactivity. They are particularly suited for applications requiring a secure knot, such as in gynecological and orthopedic surgeries. The rapid absorption profile of poliglecaprone sutures allows for effective wound closure while minimizing the risk of complications associated with suture retention. The increasing preference for poliglecaprone sutures in various surgical procedures is driven by the ongoing advancements in suture technology and the growing emphasis on patient safety, which is expected to propel market growth in this segment.

Polydioxanone :

Polydioxanone (PDO) sutures are synthetic absorbable sutures recognized for their superior tensile strength and extended absorption profile. These sutures are widely used in various surgical procedures, including cardiovascular and plastic surgeries, due to their excellent stability and minimal tissue reactivity. The unique properties of PDO sutures enable surgeons to achieve optimal wound closure while providing long-term support during the healing process. As the demand for high-performance sutures continues to rise, the market for polydioxanone sutures is expected to grow, supported by ongoing innovations and the increasing number of surgical procedures.

Polyglycolic Acid :

Polyglycolic acid (PGA) sutures are highly absorbable surgical sutures that offer excellent handling and knot security. They are characterized by their rapid absorption rate and minimal tissue irritation, making them suitable for various applications, including gastrointestinal and soft tissue surgeries. The flexibility and strength of PGA sutures provide surgeons with reliable closure options, enhancing patient safety and recovery times. The increasing adoption of PGA sutures in surgical practices, driven by the demand for effective wound closure solutions, is expected to propel market growth significantly in this segment.

Catgut :

Catgut sutures are made from the natural fibrous tissue of sheep or cattle intestines, and they have been used for centuries due to their biocompatibility and effective absorption properties. While their use has declined with the rise of synthetic materials, catgut sutures still hold a niche market in specific applications, such as general and gynecological surgeries. The resurgence of interest in biocompatible materials is leading to a gradual increase in the demand for catgut sutures, particularly in regions where cost-effectiveness and traditional practices are valued. As healthcare providers seek reliable and effective suturing options, the market for catgut sutures is expected to experience modest growth.

By Region

North America holds the largest share of the global absorbable sutures market, driven by a robust healthcare infrastructure, a high volume of surgical procedures, and increasing investments in research and development. The region's preference for advanced medical technologies, coupled with the rising incidence of chronic diseases, further contributes to the demand for absorbable sutures. The U.S. is a dominant player in this market, accounting for a significant portion of the overall revenue due to its well-established healthcare system and the presence of key market players. The North American market is expected to grow at a CAGR of approximately 6.8% during the forecast period as surgical techniques continue to evolve and healthcare providers increasingly adopt absorbable sutures for their benefits in patient care.

Europe is the second-largest market for absorbable sutures, characterized by an increasing number of surgical procedures and a growing emphasis on patient safety. The region's advanced healthcare infrastructure, coupled with rising healthcare spending, is driving market growth. Countries such as Germany, France, and the UK are prominent contributors to this region's market, where a growing preference for minimally invasive surgeries is leading to higher demand for absorbable sutures. The European market is projected to grow at a CAGR of around 5.9% during the forecast period, influenced by the ongoing advancements in surgical technologies and the rising awareness of the benefits of absorbable sutures.

Opportunities

The absorbable sutures market is presented with numerous opportunities for growth, particularly through technological advancements and product innovations. Manufacturers are increasingly focused on developing new suture materials and designs that enhance performance and meet the evolving demands of healthcare providers. Innovations such as bioactive sutures, which promote faster healing and improved tissue integration, are gaining traction. Additionally, the integration of smart technology in sutures, such as those that can monitor wound healing or deliver localized medication, represents a significant opportunity for market players. The expansion of healthcare facilities and surgical centers, particularly in emerging markets, also provides avenues for growth, as these regions are investing in advanced medical technologies to improve patient care.

Furthermore, the increasing trend of telemedicine and digital healthcare solutions presents opportunities for the absorbable sutures market to reach a broader audience. With the rise of online sales platforms, healthcare providers can easily acquire absorbable sutures, thereby enhancing their availability and accessibility. Education and training programs aimed at surgical professionals will also amplify the demand for quality suturing materials, as healthcare providers increasingly recognize the importance of effective wound closure in improving patient outcomes. The focus on minimizing healthcare costs while maintaining quality patient care will further drive the adoption of absorbable sutures, creating a favorable environment for growth.

Threats

The absorbable sutures market faces several threats that may challenge its growth trajectory. One significant concern is the potential for product recalls due to quality control issues or adverse reactions associated with certain suture materials. Such incidents can significantly impact the reputation of manufacturers and lead to decreased trust among healthcare providers. Furthermore, the rapid pace of technological advancements in the medical field poses a threat to the market, as new alternative materials or methods may emerge that could supersede traditional absorbable sutures. Competition from non-absorbable sutures, especially in certain surgical applications, may also hinder growth as some healthcare providers may prefer materials that provide longer-term support in specific cases.

Another looming threat is the regulatory landscape surrounding medical devices, including absorbable sutures. Stricter regulations and compliance requirements could pose challenges for manufacturers, increasing production costs and potentially delaying product launches. Additionally, the ongoing economic uncertainties in various regions could affect healthcare spending and investment in surgical technologies. As hospitals and surgical centers assess costs, they may opt for more economical options, impacting the demand for premium absorbable sutures. These factors combined emphasize the need for manufacturers to remain vigilant and adaptable in a competitive and evolving market.

Competitor Outlook

• Ethicon, Inc.
• Medtronic Plc
• Boston Scientific Corporation
• Sutures India Pvt. Ltd.
• Smith & Nephew Plc
• Abbott Laboratories
• B. Braun Melsungen AG
• Teleflex Incorporated
• ConvaTec Group Plc
• Advanced Medical Solutions Group Plc
• Am Surgical Inc.
• Hollister Incorporated
• Integra LifeSciences Holdings Corporation
• Oculus Surgical, Inc.
• Vygon S.A.

The competitive landscape of the absorbable sutures market is characterized by numerous players, including established companies and emerging startups. Key players focus on product innovation, expanding their product portfolios, and enhancing distribution channels to capture a larger market share. The market is also witnessing significant collaborations and partnerships aimed at enhancing research and development capabilities. Companies are investing heavily in technological advancements to develop high-performance sutures that cater to specific surgical applications. As the market becomes increasingly competitive, players are adopting strategies such as mergers and acquisitions to strengthen their positions and expand their geographical reach.

Ethicon, Inc., a subsidiary of Johnson & Johnson, is one of the leading players in the absorbable sutures market. The company offers a comprehensive range of absorbable sutures, including polyglactin, polydioxanone, and poliglecaprone sutures, which are widely used in various surgical applications. Ethicon’s commitment to innovation and patient safety has enabled it to maintain a strong presence in the market. Medtronic Plc is another key player, known for its focus on surgical technologies and solutions. The company provides a range of absorbable sutures that are designed to meet the evolving needs of healthcare providers and improve patient outcomes.

B. Braun Melsungen AG is a significant competitor in the absorbable sutures market, offering a diverse portfolio of suture products that cater to various surgical specialties. The company emphasizes quality and reliability, focusing on developing sutures that enhance surgical performance and patient safety. Similarly, Smith & Nephew Plc is recognized for its innovative products and commitment to advancing surgical techniques. The company’s absorbable sutures are designed to provide strong, effective closure solutions across various surgical applications. With ongoing efforts in research and development, these companies are positioning themselves to capture a larger share of the growing absorbable sutures market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Vygon S.A.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Ethicon, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic Plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Am Surgical Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 ConvaTec Group Plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smith & Nephew Plc
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 B. Braun Melsungen AG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Oculus Surgical, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Teleflex Incorporated
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hollister Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Sutures India Pvt. Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Advanced Medical Solutions Group Plc
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Integra LifeSciences Holdings Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Absorbable Sutures Sales Market, By Application
    • 6.1.1 General Surgeries
    • 6.1.2 Gynecological Surgeries
    • 6.1.3 Orthopedic Surgeries
    • 6.1.4 Ophthalmic Surgeries
    • 6.1.5 Others
  • 6.2 Absorbable Sutures Sales Market, By Product Type
    • 6.2.1 Natural Sutures
    • 6.2.2 Synthetic Sutures
    • 6.2.3 Composite Sutures
    • 6.2.4 Monofilament Sutures
    • 6.2.5 Multifilament Sutures
  • 6.3 Absorbable Sutures Sales Market, By Material Type
    • 6.3.1 Polyglactin
    • 6.3.2 Poliglecaprone
    • 6.3.3 Polydioxanone
    • 6.3.4 Polyglycolic Acid
    • 6.3.5 Catgut
  • 6.4 Absorbable Sutures Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Absorbable Sutures Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Absorbable Sutures Sales market is categorized based on

By Product Type

• Natural Sutures
• Synthetic Sutures
• Composite Sutures
• Monofilament Sutures
• Multifilament Sutures

By Application

• General Surgeries
• Gynecological Surgeries
• Orthopedic Surgeries
• Ophthalmic Surgeries
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Sales

By Material Type

• Polyglactin
• Poliglecaprone
• Polydioxanone
• Polyglycolic Acid
• Catgut

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Ethicon, Inc.
• Medtronic Plc
• Boston Scientific Corporation
• Sutures India Pvt. Ltd.
• Smith & Nephew Plc
• Abbott Laboratories
• B. Braun Melsungen AG
• Teleflex Incorporated
• ConvaTec Group Plc
• Advanced Medical Solutions Group Plc
• Am Surgical Inc.
• Hollister Incorporated
• Integra LifeSciences Holdings Corporation
• Oculus Surgical, Inc.
• Vygon S.A.